Pathomorphology is correlated with visual acuity changes

Article

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea claims a study in the American Journal of Ophthalmology.

Dr Tomoaki Murakami and his team at the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, used 125 consecutive eyes of 73 patients in a retrospective, observational study.

All patients underwent spectralis optical coherence tomography (OCT) and the outcome measures were status of external limiting membrane (ELM), cystic changes and pathomorphology. The correlation of logarithm of the minimal angle of resolution (logMAR) was studied.

Three types of pathomorphology were identified at the fovea. These included cystoid macular oedema (CME), serous retinal detachment (SRD) and a lack of CME or SRD. The average logMAR with the CME pathomorphology was worse than the SRD pathomorphology.

It was found that parafoveal thickening or disturbed ELM was strongly correlated with low VA. However, SRD did not have a strong correlation with VA.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.